Treatment of advanced Wegener's granulomatosis with azathioprine and duazomycin A.
D000328:Adult; D000917:Antibody Formation; D000963:Antimetabolites / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D001391:Azo Compounds / Q000627:therapeutic use*; D003980:Diazooxonorleucine / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006386:Hemagglutination Tests; D006801:Humans; D007668:Kidney / Q000473:pathology; D007677:Kidney Function Tests; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D012882:Skin Tests
D000963:Antimetabolites; D001391:Azo Compounds; D003980:Diazooxonorleucine; D001379:Azathioprine; D011241:Prednisone